Molecular Breast Imaging in Women With Atypia and LCIS

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Atypical Lobular HyperplasiaAtypical Ductal HyperplasiaLobular Carcinoma in Situ
Interventions
PROCEDURE

Molecular Breast Imaging

Molecular breast Imaging is a new nuclear medicine technique for imaging the breast. It uses small filed of view semiconductor-based gamma cameras that use Cadmium Zinc Telluride detectors. These have superior spatial and energy resolution to conventional sodium iodide detectors.

PROCEDURE

Screening Mammography

A screening mammogram is used to look for signs of breast cancer in women who don't have any breast symptoms or problems. X-ray pictures of each breast are taken from 2 different angles.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Susan G. Komen Breast Cancer Foundation

OTHER

lead

Mayo Clinic

OTHER

NCT00620087 - Molecular Breast Imaging in Women With Atypia and LCIS | Biotech Hunter | Biotech Hunter